Sai Parenterals to Acquire Majority Stake in Bion Therapeutics
Sai Parenterals Ltd · Others (Uncategorized) · 17 Nov 2026, 2:35 am
Sai Parenterals to Acquire Majority Stake in Bion Therapeutics Sai Parenterals approved acquiring a majority stake in Hyderabad-based Bion Therapeutics India via its wholly owned subsidiary, SP Analytics, in an all-cash deal expected to close by 30th Nov'26. The transaction will be funded through IPO proceeds earmarked for general corporate purposes and debt. Bion Therapeutics, a branded formulations prescription business, reported total income of ₹47.14 Cr in FY25, ₹47.29 Cr in FY26, and ₹28.75 Cr for H1FY27 ended 30th Sep'26. Valuation will be determined by an independent valuer.
Original exchange filing (PDF)
More announcements from Sai Parenterals Ltd
- Press Release by Sai Parenteral''s Limited · 17 Nov 2026
- call conducted on Monday the 2nd day of November, 2026. · 07 Nov 2026
- Audio recording of earning call held on 2nd November, 2026 over call. · 03 Nov 2026
- Investor Presentation for the quarter and half year ended 30th September, 2026 · 02 Nov 2026
- Investor press release on standalone and consolidated unaudited financial results for the quarter ended 30th September, 2026. · 01 Nov 2026
- Statement of variation and deviation for the period ended 30th September, 2026 · 01 Nov 2026
- Financial Results · 01 Nov 2026
- Sai Parenterals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 01 Nov 2026
